Touchlight at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Touchlight brings 3 presentations to ESGCT 2026 in Hamburg. Its contribution centres on enzymatically made DNA as a replacement for plasmids. Work compares the cost of goods against plasmid DNA in AAV production and shows templates that transcribe messenger RNA efficiently with less double-stranded RNA impurity.

OrganizationESGCT 2026 Attendance
Touchlight
London, UK
CDMOs & CROs
Makes doggybone DNA (dbDNA), an enzymatically produced linear DNA used instead of plasmids for mRNA, AAV and lentiviral vector manufacturing.
Poster
Thu Oct 29
2:00pm–4:00pm
A comparative cost of goods analysis of dbDNAä and plasmid DNA for AAV gene therapy manufacturing
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
Enzymatically produced z-dbDNA templates enable efficient in vitro transcription with reduced DNA input and lower double-stranded RNA impurity compared to pDNA templates
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Reimagining DNA Payloads: Enzymatic Circular DNA for the Next Generation of Cell and Gene Therapies
Gene Editing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Touchlight

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction